logo
EXCLUSIVE Harvard doctor: I was on the cusp of a cure for cancer, then Trump cut my funding... now thousands could die needlessly

EXCLUSIVE Harvard doctor: I was on the cusp of a cure for cancer, then Trump cut my funding... now thousands could die needlessly

Daily Mail​25-04-2025

A Harvard doctor studying cutting-edge therapies for cancer and lung disease has revealed how his research has been brutally axed by President Trump.
Dr John Quackenbush detailed the sudden cut to his funding to understand how the devastating diseases affect and progress differently in men and women - a hurdle that has stifled progress on finding cures.
The 63-year-old scientist who has been a professor at the prestigious university for the last 20 years explained that the about $2.4 million research project was meant to find personalized and improved treatments for both sexes.
The project had been submitted in November 2020 and was approved by former President Joe Biden 's administration in September 2021 - but the grant was axed with no prior notice on April 4 this year.
Dr Quackenbush believes it was wrongly terminated as part of the Trump administration's crackdown on the government's bankrolling of diversity, equity and inclusion (DEI) research projects.
He told DailyMail.com that the funding slashes will worsen the research crisis and set medical advancement back by decades.
'Females have twice the lifetime risk of developing Alzheimer's than males do,' he added. 'Males have a much higher risk of developing colon cancer but respond better to chemotherapy.
'We know and have known for decades that many diseases are different in males or females. But nobody has been able to scratch the surface of why these differences exist and how we might be able to use these differences to better treat disease in everyone.'
'So, I submitted a grant application about four years ago in which we had proposed to better understand what drives some of these differences,' the Professor noted.
The project has already contributed to nearly 30 peer-reviewed papers on new methods that shed light on sex differences in managing chronic diseases.
The professor of bioinformatics at the T.H. Chan School of Public Health revealed that his team had submitted an application, asking the National Institute of Health for a renewal of their ongoing project in November 2024 during the Presidential election.
But while applications are usually reviewed and approved within months, theirs kept being delayed.
'It was supposed to first be reviewed in February, then we found out it's going to be reviewed in March, then we found out it's going to be reviewed at the end of March, then we found out it was going to be reviewed in April.
'About two weeks ago, we checked on the NIH website and there was no date for the review. And we were astonished, because everything pointed to this grant being reviewed.'
After seeing the sudden change in their application status, Dr Quackenbush approached their program officer for information.
But much to his dismay, the official told him that the specific program they had applied to had been terminated by the federal government.
This program, announced in a 2022 Notice of Funding Opportunity (NOFO) published by the NIH, solicited research grant proposals to address 'gaps in our current understanding of diseases and conditions in women are the result of the continued over-reliance on male models'.
Dr Quackenbush believes it was a part of the latest budget cuts by the Trump administration as it did not align with current policy.
He said: 'They're not just terminating grants, they're terminating whole programs that are funding research into areas that don't align with current policy.
'And you know, we shouldn't be in a position where the the opinions of individuals in government about what's appropriate or what's inappropriate should be dictating how we look at these fundamental scientific questions.
'The cuts that are happening are kind of across the board. It's almost happening at random. It's completely irrational. There's sort of no rhyme or reason about any of this.'
On January 20, President Donald Trump signed an executive order halting all 'equity-related' federal grants or contracts in an effort to end Diversity, Equity and Inclusion (DEI) programs.
Scientists have since alleged that agency officials are being told not to approve grants that include the words 'women,' 'gender' or 'diversity' - of which comparing disease in men and women was a focus Dr Quackenbush's project.
In an April 11 letter to Harvard, the Trump administration called for broad government and leadership reforms at the university and changes to its admissions policies
In the US, it is estimated that nearly 1million women receive a cancer diagnosis each year, while an estimated one in two men will be diagnosed with cancer at some point in their lives.
Prostate cancer is the most common form of cancer in men in the US, with 35,000 men dying the disease each year.
Meanwhile, breast cancer is the most common cancer in women - killing over 40,000 each year.
Since submitting the project in 2021, the Professor and his team have made 'tremendous progress' but now these cancellations threaten long-term research and training, potentially delaying future treatments by years.
Their groundbreaking research has already contributed to nearly 30 other peer-reviewed papers that have focused on state-of-the-art forms of treatment and their application for a range of chronic illnesses including cancers and chronic obstructive pulmonary disease - a progressive lung disease that makes it difficult to breathe.
He commented: 'If scientists [are] really committed to improving the human condition, then we should be in a position to look at health in everyone, to understand how to improve the health of everyone and that should be our fundamental priority.
'And you know, we shouldn't be in a position where the the opinions of individuals in government should override scientifically sound approaches to addressing basic questions in human health.
In an April 11 letter to Harvard, the Trump administration called for broad government and leadership reforms at the university and changes to its admissions policies.
It also demanded the university audit views of diversity on campus and stop recognizing some student clubs - arguing that campuses had allowed antisemitism to go unchecked at protests last year.
However, Harvard President Alan Garber refused to agree and hours later, the government froze over $2.2 billion in federal scientific grants given to the University.
When asked why the current administration had targeted Harvard's medical research in regards to anti-Semitic harassment, Dr Quackenbush said: 'The rationalization that is being presented to the general public is absolutely ludicrous.
'If there are allegations of anti-Semitism against Harvard or any other university, the rational approach would be to do an investigation to find out what the causes are, to find out whether or not the responses were appropriate and to take steps to remedy that, to prevent it from happening.'
He also told the website that the halt in federal grants not only impacted medical research but also put generations of upcoming scientists and their discoveries in jeopardy.
'We use this [money] to train the next generation of scientists. Our PhD students and our postdoctoral fellows, the training they get is largely an apprenticeship.
'My PhD students come and work with me because we're going to go into the lab and we're going to work together, they're going to see how to do science and they're going to learn by doing it. You take away my research grants, you take away my abilities and train the next generation.
'We're seeing people who are doing science get laid off. We're seeing projects that were had been running for years being terminated. Even if they turned on the funding tomorrow, the damage is done.
'It takes years to build a research program, and as we're seeing, it takes just minutes to potentially destroy that in ways that could take even longer to rebuild. And we're not making these choices for rational reasons.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

US NIH director says hopeful will settle with universities over suspended grants
US NIH director says hopeful will settle with universities over suspended grants

Reuters

time3 hours ago

  • Reuters

US NIH director says hopeful will settle with universities over suspended grants

WASHINGTON, June 10 (Reuters) - National Institutes of Health Director Jay Bhattacharya told a U.S. Senate panel on Tuesday he was hopeful that President Donald Trump's administration would reach a settlement with universities that have had research grants suspended. "I'm very hopeful that a resolution being made with the universities where those decisions have been made, where those grants have been paused," Bhattacharya said while appearing at a hearing of the Senate Appropriation Committee's Subcommittee on Labor, Health and Human Services, Education, and Related Agencies on the NIH's 2026 budget request. The NIH has terminated 2,100 research grants totaling about $9.5 billion and an additional $2.6 billion in contracts since Trump took office Jan. 20, dozens of scientists, researchers and other employees at the agency said in a public letter. The contracts often support research, from covering equipment to nursing staff working on clinical trials.

US aid cuts threaten South Africa's status as powerhouse of HIV and tuberculosis research
US aid cuts threaten South Africa's status as powerhouse of HIV and tuberculosis research

Telegraph

time4 hours ago

  • Telegraph

US aid cuts threaten South Africa's status as powerhouse of HIV and tuberculosis research

South Africa risks losing its status as a powerhouse of HIV and tuberculosis research as sweeping American funding cuts jeopardise dozens of experimental trials. At least 27 HIV trials and another 20 TB trials in the country have been put at risk by Donald Trump's deep cuts to foreign assistance and global health spending, new analysis shows. Loss of the trials would hit research projects looking for new vaccines into both infections, as well as new long-lasting protective medicines and studies into the best way to treat children. Having intense HIV and TB epidemics as well as world class universities and research institutes has made South Africa a leader in combating the two diseases. Yet while the research has often been led by South African scientists, it has overwhelmingly been conducted with international funding, particularly with 20 years of generous United States government aid spending. Prof Salim Abdool Karim, director of the Centre for the Aids Program of Research in South Africa, said: 'The US is such a big player in our country – South Africa is a powerhouse in medical research because of what the US spends.' The bulk of funding for research came from the US National Institutes of Health (NIH), with the country receiving an estimated £111m ($150m) each year. Prof Ntobeko Ntusi, the president and chief executive of the South African Medical Research Council (SAMRC), said earlier this year: 'In many ways the South African health research landscape has been a victim of its own success, because for decades we have been the largest recipients of both [official development assistance] funding from the US for research [and] also the largest recipients of NIH funding outside of the US.' Now, unless alternative sources of money can be found, South African academic and research institutes could lose about 30 per cent of their annual income and may be forced to lay off hundreds of staff, the analysis found. 'There's been a huge dependence on US funding. The loss of it for South Africa means the cancellation of a huge amount of research,' said Tom Ellman, director of the MSF's Southern Africa Medical Unit (SAMU). The joint analysis by Treatment Action Group (TAG) and Doctors Without Borders (MSF) of NIH-funded research found 39 TB and HIV clinical research sites are under threat, placing at least 27 HIV trials and 20 TB trials at risk. The effect of cuts could be wider still, with research also funded through other US channels, including the US President's Emergency Plan for Aids Relief (Pepfar), which has been slashed by Donald Trump's administration. Global research 'in peril' Lindsay McKenna, TB project co-director of TAG said: 'Public funding from the US government to South Africa is the scaffold on which pharmaceutical companies, philanthropies, and other governments invest in transformative TB and HIV science.' 'These ongoing funding disruptions by the US government don't just affect US-funded research projects, they put in peril a much wider ecosystem of global research.' Dr Ellman said a combination of the infections found in South Africa, its research base and its strong grass roots activism had combined, with US funding, to make the country so prominent in research. He said: 'For years, South Africa has spearheaded the research and development of critical innovative medical tools for the prevention, diagnosis, treatment and care of HIV and TB which have saved lives not just within South Africa's borders, but also in communities worldwide.' The country has more HIV patients than any other, with an estimated 8 million currently infected and 105,000 deaths annually. The high prevalence of HIV goes hand-in-hand with a high prevalence of tuberculosis, because TB takes advantage of patients' weakened immune systems. Tuberculosis is the biggest cause of death among those with HIV in South Africa, which recorded 54,000 TB deaths in 2023. At the same time, the country has strong research institutions and universities, and a history of medical innovation, including conducting the first heart transplant in 1969. Finally, the history of the apartheid struggle, and later the fight in the early 2000s to get antiretroviral drugs in the face of government AIDS denialism, has produced well-organised and politically-engaged health activists. According to the joint analysis, HIV trials now at risk include studies into using broadly neutralising antibodies (bNAbs) to find a cure, and also trials into long-lasting anti-HIV preventative jabs. The Brilliant Consortium, a collaboration of African researchers led by the SAMRC working to develop an HIV vaccine, lost all funding even as it was about to begin an early stage vaccine trial. Dr Ellman said: 'I think it would be a disaster if we gave up on the hope of finding an effective vaccine for HIV. All of that has been done with South Africa and without access to South African research and communities, it's not going to be possible.' The emergence of some resistance to antiretroviral drugs has also highlighted the importance of trials to find new drugs which can deal with the phenomenon. HIV trials are also looking at honing and improving existing treatment regimes, as well as simplifying and rolling out expensive techniques first used in the developing world. TB trials at risk include studies for new drugs and shorter, safer regimens for treatment and prevention. The cuts have a ripple effect beyond individual trials, because they also weaken research infrastructure which is used and relied on by other funders. That could have a knock-on effect on trials looking at new TB jab possibilities, including the promising new M72/AS01E vaccine candidate. South Africa is now scrabbling for alternative sources of funding to try to salvage as many of the research projects as possible. Dr Ellman said: 'We call on all potential donors to step up, as without sustained investment, we will never end these deadly epidemics.'

The 2-second at-home test that can reveal your risk of 8 nasty conditions – including killer stroke and Alzheimer's
The 2-second at-home test that can reveal your risk of 8 nasty conditions – including killer stroke and Alzheimer's

Scottish Sun

time8 hours ago

  • Scottish Sun

The 2-second at-home test that can reveal your risk of 8 nasty conditions – including killer stroke and Alzheimer's

Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) A TEST you can do at home in matter of seconds - with a bag of sugar, an air fryer or even a pet - could reveal your risk eight diseases. Do you have difficulty picking up an object weighing 5 kilograms after a certain age? Sign up for Scottish Sun newsletter Sign up 1 Declining muscle strength is linked to a higher risk of dementia or stroke Credit: Getty If so, you run the risk of developing conditions such as chronic lung disease, arthritis, stroke and Alzheimer's disease, according to researchers from the University of Sharjah in the United Arab Emirates. As we get older, our muscles naturally weaken. Muscle and hand grip strength have long been used as indicators of disease risk and can serve as a warning of declining health. But the current tools used by doctors can be expensive, meaning only clinics can afford them. Researchers set out find a simpler and more accessible method of assessing muscle strength without the use of specialised tools - finding that objects lying around at home can also be reliable indicators. Professor Rizwan Qaisar, the study's first author, said: "Imagine you're at home, and you pick up a bag of groceries, maybe something that weighs about 5 kg - like a big bag of sugar or a small kitchen appliance. "If you find yourself struggling with that, it might seem like a small thing, but our research shows it could be a really important clue about your health." Scientists conducted their investigation using data from 51,536 adults from 15 countries who were aged 50 and older. "We tracked them over time to see if their ability to lift 5 kg was connected to developing various health conditions in the future. What we found was quite significant," Prof Qaisar said. "People who reported difficulty lifting 5 kg had a significantly higher risk of experiencing a lower quality of life, higher rates of depression, chronic lung diseases, hip fractures, joint disorders, high cholesterol, Alzheimer's disease, stroke, and osteoarthritis. 10 second one leg stand test "Interestingly, this connection held regardless of their age or gender. "Our findings strongly suggest that this simple, everyday test could be a valuable early indicator of overall health and potential future health challenges." Researchers conducted their study over a five year period. Participants were asked to report if they had any difficulty doing various everyday activities at the outset of the study, as well their age, gender and country of residence. Those who had one of the diseases in question at the start of the study were excluded from analysis. One of the activities was 'lifting or carrying weights over 5 kilos', which became the central point of the researchers' analysis. "The 5kg threshold was selected due to its relevance to everyday household objects, such as a standard bag of sugar or all-purpose flour, an average house cat, an air fryer, a portable slow cooker, and the cast iron Dutch oven," they wrote. "Thus, the study provides a practical and accessible measure of muscle strength and overall health within the domestic environment." Ways to improve your strength A strength exercise is any activity that makes your muscles work harder than usual. This increases your muscles' strength, size, power and endurance. The activities involve using your body weight or working against a resistance. You should try to do two sessions or more of muscle strengthening exercises a week. Examples of muscle-strengthening activities include: Lifting weights Working with resistance bands Heavy gardening, such as digging and shovelling Climbing stairs Hill walking Cycling Dance Push-ups, sit-ups and squats Yoga Source: NHS Study participants were also asked to fill out a quality of life questionnaire - which included such as 'how often do you think your age prevents you from doing the things you would like to do?' - and had symptoms of depression assessed too. From the 51,536 respondents, 10,025 (19.5 per cent) had difficulty lifting 5kg at the start of the study. Over the follow-up period, researchers found that people who had difficulty picking up 5kg objects had a higher risk of reporting a low quality of life (9 per cent), depression (8 per cent) and osteoarthritis (7 per cent). They also had a mild to moderate risks of having "rheumatoid arthritis, heart attack, diabetes mellitus, hypertension, Alzheimer's disease, stroke, or hip fracture", according to researchers. Study authors found that women had a higher risk of various diseases than men. They said muscle weakness could be indicative of several things. "First, muscle weakness in these participants suggests a sedentary lifestyle and low physical activity, which are risk factors for several diseases reported here. "For example, a sedentary lifestyle is associated with higher risks of depression, cardiovascular diseases, metabolic disorders, and neurological deficits. "Participants with difficulty lifting 5kg will likely exhibit muscle wasting," they went on. "Muscle mass is a significant protein reserve that protects against organ degeneration due to trauma, diseases, and/or ageing. Thus, a low muscle mass in the participants with difficulty lifting 5kg of weight can predispose them to develop chronic diseases." Finally, muscle weakness could be connected to inflammation. "It is also established that chronic low-grade inflammation can cause and/or exacerbate various cardiovascular, neurological, and metabolic disorders reported in this study," researchers stated. Study co-author Dr Fabio Franzese from SHARE Berlin Institute in Germany, said: "Muscle weakness isn't just a sign of ageing; it's a profound warning for future disease." That's why the "simple act" of trying pick up 5kg with "no fancy equipment" can be "a powerful health predictor". "Our findings put early health assessment in everyone's hands," he said. Prof Qaisar added: "Before major illness, there's often a subtle struggle. This test offers a crucial window for intervention. "The test empowers people to seek early medical advice, motivates healthier lifestyle choices, and offers health care providers a valuable preliminary screening tool to identify at-risk individuals, ultimately improving preventive care and public health outreach for older populations."

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store